Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Novartis Drug for Smoker’s Cough Boosts Lung Function in Study
Novartis’s experimental drug for smoker’s cough helped patients in a late-stage trial, and was at least as good as a treatment sold by Boehringer Ingelheim and Pfizer.
Copyright ©2014. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing